soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 found to lower risk of heart failure events in people with type 2 diabetes Oral Semaglutide's Impact on Cardiovascular

References FDA Approves Lillys Foundayo (orforglipron), Only GLP-1 Pill for Weight Loss

2.74k views 73 slides Indications for IV Insulin Infusion Diabetic ketoacidosisNon-ketotic hyperosmolar stateCritical care illness (surgical)Myocardial infarction or cardiogenic shockPost-operative period following heart surgery

The face loses fat volume alongside the rest of the body, and because facial fat is structural, its loss has consequences that are immediately visible

If you have Type 2 diabetes, the medications help manage your blood sugar by triggering your pancreas to release more insulin

A: It is generally well tolerated

Transdermal Estrogen Therapy Improves Gains in Skeletal Muscle Mass After 12 Weeks of Resistance Training in Early Postmenopausal Women. Frontiers in Physiology , vol